Implementation of new endovenous treatments in therapy for lateral embryonic veins.

Huegel, Ulrike; Baumgartner, Iris (2019). Implementation of new endovenous treatments in therapy for lateral embryonic veins. Journal of vascular surgery cases and innovative techniques, 5(3), pp. 243-247. Elsevier 10.1016/j.jvscit.2018.12.016

[img]
Preview
Text
1-s2.0-S2468428719300164-main.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (904kB) | Preview

Klippel-Trénaunay syndrome is characterized by a persistent lateral embryonic vein. This so-called marginal vein has a large diameter causing venous stasis and venous hypertension because of the absence of valves along its entire length. The extensive diameter of the vein impedes successful treatment by sclerotherapy. Surgical removal is considered technically challenging for potential severe intraoperative blood loss due to the large perforators to the deep veins. Here we show that endovenous treatments (laser ablation, cyanoacrylate adhesive) might be feasible options in therapy for lateral embryonic veins.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology

UniBE Contributor:

Hügel, Ulrike and Baumgartner, Iris

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2468-4287

Publisher:

Elsevier

Language:

English

Submitter:

Catherine Gut

Date Deposited:

24 Jan 2020 17:18

Last Modified:

24 Jan 2020 17:26

Publisher DOI:

10.1016/j.jvscit.2018.12.016

PubMed ID:

31304432

Uncontrolled Keywords:

Cyanoacrylate Endovenous laser Klippel-Trénaunay syndrome Marginal vein

BORIS DOI:

10.7892/boris.137601

URI:

https://boris.unibe.ch/id/eprint/137601

Actions (login required)

Edit item Edit item
Provide Feedback